• AXIS Clinicals successfully completes 14th US FDA audit (June 2016)
  • AXIS Clinicals successfully completes US FDA audit for ICP-OES services (March 2016)
  • AXIS Clinicals successfully completes 7th ANVISA – Brazil audit (March 2015)
  • AXIS Clinicals successfully completes WHO audit (March 2015)
  • AXIS Clinicals successfully completes 3rd MHRA audit (Sep 2014)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Medical Writing

Medical writing in the context of Clinical Research undoubtedly plays a crucial role in the success or failure of new compounds. AXIS Clinicals’ medical writing domain is well equipped with professionals having strong academics besides having valuable scientific experience in various therapeutic areas; help to compile, organize, write, edit and produce a wide range of medical and scientific documentation essential to deliver the quality and timeliness required to support the product development efforts.

Our clients can safely bank on our writers at any stage in their product development lifecycle – from clinical development plan and investigator brochures to regulatory submission and licensing maintenance documents. Having in-house expertise from PK|PD to pharmaco-vigilance, we are capable to work on study reports, patient narratives, DSMB updates, labeling or other documents involving study data.

The Medical Writing services at AXIS Clinicals is proficient in:

  • Clinical development plans
  • Abstracts, manuscripts and journal articles
  • Investigator brochures and annual updates
  • Informed consent forms
  • Protocols
  • Clinical study reports
  • Clinical sections of Common Technical Documents (CTDs)
  • Clinical sections of New Drug Applications (NDAs)
  • Periodic Safety Update Reports (PSURs) and other pharmaco-vigilance documents
  • Pre-FDA meeting briefing documents
  • Response to clinical hold orders
  • Preclinical study reports, expert reports and summaries
  • Data Safety Monitoring Board (DSMB) manuals
  • Written and tabular summaries


Bio-Analytical Reporting

  • Method Validation Reports
  • Bio analytical Reports
  • ISR Reports
  • Submission-ready Documentation (Hyperlinked eCTD formatting)
  • Dispatch & Archival
  • Benefit | Risk assessment reports apart from medical and scientific literature reviews

Our unique medical writing offerings are in strict adherence with ICH guidelines and similar regulatory requirements.


 

Fact sheet

  • Over 1,600 clinical studies completed since inception
  • Over 290 bioanalytical methods developed
  • Over 38 successful Regulatory audits
  • Global footprint of operations with sites in India, U.S, Mexico & Thailand.
  • Two clinical facilities in India
  • 60+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 200+ approvals, EMEA : 70+ approvals, Canada : 20+ approvals, Australia : 30+ approvals
  • 350+ staff working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved

Design By Graypixel